United Services Automobile Association’s BioCryst Pharmaceuticals BCRX Stock Holding History

United Services Automobile Association’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-14,777	Closed	-$56K	–	573
2019 Q2	$56K	Hold	14,777	–	–	﹤0.01%	2169
2019 Q1	$120K	Hold	14,777	–	–	﹤0.01%	2141
2018 Q4	$119K	Hold	14,777	–	–	﹤0.01%	2110
2018 Q3	$113K	Hold	14,777	–	–	﹤0.01%	2219
2018 Q2	$85K	Hold	14,777	–	–	﹤0.01%	2225
2018 Q1	$70K	Buy	+14,777	New	+$75.9K	﹤0.01%	2202
2016 Q1	–	Sell	-115,116	Closed	-$1.19M	–	1283
2015 Q4	$1.19M	Buy	115,116 +1,510	+1%	+$15K	﹤0.01%	1047
2015 Q3	$1.29M	Sell	113,606 -5,500	-5%	-$73.4K	﹤0.01%	1019
2015 Q2	$1.78M	Buy	119,106 +3,610	+3%	+$41K	0.01%	1008
2015 Q1	$1.04M	Buy	115,496 +8,690	+8%	+$90K	﹤0.01%	1117
2014 Q4	$1.3M	Buy	106,806 +3,000	+3%	+$33.1K	﹤0.01%	1062
2014 Q3	$1.01M	Hold	103,806	–	–	﹤0.01%	1088
2014 Q2	$1.32M	Buy	103,806 +1,100	+1%	+$10.7K	﹤0.01%	1029
2014 Q1	$1.09M	Sell	102,706 -25,370	-20%	-$270K	﹤0.01%	1069
2013 Q4	$973K	Buy	+128,076	New	+$811K	﹤0.01%	1090

Other funds holding BCRX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

United Services Automobile Association's BCRX Position: Q3 2019 in Review

United Services Automobile Association sold out of BioCryst Pharmaceuticals (BCRX) in Q3 2019, closing a stake of 14,777 shares — an estimated $56K sold.

United Services Automobile Association first reported a position in BCRX in Q4 2013 and held it in 15 quarters. The position peaked at $1.78M in Q2 2015. 115 funds tracked by Wall St. Rank hold BCRX as of Q3 2019.

United Services Automobile Association reported no remaining BioCryst Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
United Services Automobile Association sold 14,777 BioCryst Pharmaceuticals shares in Q3 2019, an estimated $56K.
United Services Automobile Association first reported a position in BioCryst Pharmaceuticals in Q4 2013 and held it in 15 quarters.
United Services Automobile Association's BioCryst Pharmaceuticals position peaked at $1.78M in Q2 2015.
115 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.